We’re extremely proud to share that the ongoing CELEBRATE trial was voted Hollands best interventional cardiology trial today, at the DRES Meeting 2022 in Nijkerk, The Netherlands.

“Let’s CELEBRATE!”, said Sem A.O.F. Rikken, PhD Candidate Cardiology, St. Antonius Hospital Nieuwegein, Cardiovascular Research Institute Maastricht.

Big congratulations to all involved on this achievement.

Arnoud van ’t Hof, M.D., Ph.D., FESC, Head of the Department of Interventional Cardiology, MUMC+, the Netherlands is the principal investigator of CELEBRATE. CeleCor Therapeutics, Inc. is the study sponsor and Diagram Research is the Contract Research Organisation (CRO).

We’d also like to take this opportunity to congratulate The Dutch Cangrelor Registry on their nomination.

DRES 2022 Sem Rikken
DRES 2022 | Nijkerk (NL) | Sem Rikken